Publications

PUBLICATIONS (2016 – 2017)

A difficult decision: Atypical JC polyomavirus encephalopathy in a kidney transplant recipient

Bialasiewicz S, Hart G, Oliver K, Agnihotri SP, Koralnik IJ, Viscidi R, Nissen MD, Sloots TP, Burke MT, Isbel NM, Burke J.

Transplantation. 2016 Jun 30

Analysis of microbiota in first episode psychosis identifies preliminary associations with symptom severity and treatment response

Schwarz E, Maukonen J, Hyytiainen T, KieseppÓ“, Oresic M, Sabunciyan S, Mantere O, Saarela M,

Yolken R, Suvisaar J.

Schizophr Res. 2017, Apr 22; S0920-9964

Anti-NMDA receptor autoantibodies and associated neurobehavioral pathology in mice are dependent on age of first exposure to Toxoplasma gondii

Kannan G, Crawford JA, Yang C, Gressitt KL, Ihenatu C, Krasnova IN, Cadet JL, Yolken RH, Severance EG, Pletnikov MV.

Association of cognitive function and liability to addition with childhood herpesvirus infections: A prospective cohort study

Vanyukov MM, Nimgaonkar VL, Kirisci L, Kirillova GP, Reynolds MD, Prasad K, Tarter RE, Yolken RH.

Dev Psychopathol. 2017 Apr 19:1-10

Association of depressed mood with Herpes Simplex Virus-2 immunoglobulin-g levels in pregnancy

Hsu PC, Yolken RH, Postolache TT, Beckie TM, Munro CL, Groer MW.

Psychosom Med. 2016 Oct;78(8):966-972

Association of DNA methylation differences with schizophrenia in an epigenome-wide association study

Montano C, Taub MA, Jaffe A, Briem E, Feinberg JI, Trygvadottir R, Idrizi A, Runarsson A, Berndsen B, Gur RC, Moore TM, Perry RT, Fugman D, Sabunciyan S, Yolken RH, Hyde TM, Kleinman JE, Sobell JL, Pato CN, Pato MT, Go RC, Nimgaonkar V, Weinberger DR, Braff D, Gur RE, Fallin MD, Feinberg AP.

JAMA Psychiatry. 2016 May 1;73(5):506-14

Autism with intellectual disability is associated with increased levels of maternal cytokines and chemokines during gestation

Jones KL, Croen LA, Yoshida CK, Heuer L, Hansen R, Zerbo O, DeLorenze GN, Kharrazi M, Yolken R, Ashwood P, Van de Water J.

Mol Psychiatry. 2017 Feb;22(2):273-279

Behavioral abnormalities in a mouse model of chronic toxoplasmosis are associated with MAG1 antibody levels and cyst burden

Xiao J, Li Y, Prandovszky E, Kannan G, Viscidi RP, Pletnikov MV, Yolken RH.

PLoS Negl Trop Dis. 2016 Apr 28;10(4):e0004674

Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder

Severance EG, Gressitt KL, Stallings CR, Katsafanas E, Schweinfurth LA, Savage CL, Ademos MB, Sweeney KM, Origoni AE, Khushalani S, Leweke FM, Dickerson FB, Yolken RH.

NPJ Schizophr. 2016 May 4;2:10618

Central nervous system-specific consequences of simian immunodeficiency virus Gag escape from major histocompatibility complex class I-mediated control

Beck SE, Queen SE, Viscidi R, Johnson D, Kent SJ, Adams RJ, Tarwater PM, Mankowski JL.

J Neurovirol. 2016 Aug; 22(4):498-507

Cerebral complement C1q activation in chronic Toxoplasma infection

Xiao J, Li Y, Gressitt KL, He H, Kannan G, Schultz TL, Svezhova N, Carruthers VB, Pletnikov MV, Yolken RH, Severance EG.

Brain Behav Immun. 2016 Nov;58:52-56

CLASS2: accurate and efficient splice variant annotation from RNA-seq reads

Song L, Sabunciyan S, Florea L

Nucleic Acids Res. 2016 Jun 2:44(10):e98

Comparison of three cell-based drug screening platforms for HSV-1 infection.

D’Aiuto L, Williamson K, Dimitrion P, McNulty J, Brown CE, Dokuburra CB, Nielsen AJ, Lin WJ, Piazza P, Schurdak ME, Wood J, Yolken RH, Kinchington PR, Bloom DC, Nimgaonkar VL

Antiviral Res. 2017 Jun;142:136-140

Consistently altered expression of gene sets in postmortem brains of individuals with major psychiatric disorders

Darby MM, Yolken RH, Sabunciyan S.

Transl Psychiatry. 2016 Sep 13;6(9):e890

Effects of cumulative Herpesviridae and Toxoplasma gondii infections on cognitive function in healthy, bipolar, and schizophrenia subjects

Hamdani N, Daban-Huard C, Godin O, Laouamri H, Jamain S, Attiba D, Delavest M, Lépine JP, Le Corvoisier P, Houenou J, Richard JR, Yolken RH, Krishnamoorthy R, Tamouza R, Leboyer M, Dickerson FB.

J Clin Psychiatry. 2017 Jan;78(1):e18-e27

Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring

Allswede DM, Buka SL, Yolken RH, Torrey EF, Cannon TD

Schizophr Res. 2016 Apr;172(1-3):41-5

Enol ethers as carbonyl surrogates in a modification of the Povarov synthesis of 3-aryl quinolones and their anti-Toxoplasma activity

Brown CE, McNulty J, Bordon C, Yolken R, Jones-Brando L.

Org Biomol Chem. 2016 Jul 7;14(25):5951-5

Hepatitis C Virus antibody titers associated with cognitive dysfunction in an asymptomatic community-based sample

Ibrahim I, Salah H, El Sayed H, Mansour H, Eissa A, Wood J, Fathi W, Tobar S, Gur RC, Gur RE, Dickerson F, Yolken RH, El Bahaey W, Nimgaonkar V.

J Clin Exp Neuropsychol. 2016 Oct;38(8):861-1

Human Papillomavirus (HPV) L1 serum antibodies and the risk of subsequent oral HPV acquisition in Men: The HIM Study

Pierce Campbell CM, Viscidi RP, Torres BN, Lin HY, Fulp W, Abrahamsen M, Lazcano-Ponce E, Villa LL, Kreimer AR, Giuliano AR.

J Infect Dis. 2016 Jul 1:214(1):45-8

Immuno-psychiatry: an agenda for clinical practice and innovative research

Leboyer M, Berk M, Yolken RH, Tamouza R, Kupfer D, Groc L.

BMC Med. 2016 Oct 28;14(1):173

Impact of serum antibodies to HPV Serotypes 6, 11, 16, and 18 to risks of subsequent genital HPV infections in men: the HIM Study

Pamnani SJ, Sudenga SL, Viscidi R, Rollison DE, Torres BN, Ingles DJ, Abrahamsen M, Villa LL, Lazcano-Ponce E, Salmeron J, Quiterio M, Huang Y, Borenstein A, Giuliano AR

Cancer Res. 2016 Oct 15;76(20):6066-6075

Individuals hospitalized with acute mania have increased exposure to antimicrobial medications

Yolken R, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, Schweinfurth L, Stallings C, Sweeney K, Dickerson F.

Bipolar Disord. 2016 Aug;18(5):404-9

Infection and characterization of Toxoplasma gondii in human induced neurons from patients with brain disorders and healthy controls

Passeri E, Jones-Brando L, Bordon C, Sengupta S, Wilson AM, Primerano A, Rapoport JL, Ishizuka K, Kano S, Yolken RH, Sawa A.

Microbes Infect. 2016 Feb;18(2):153-8

Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study

Kohler O, Petersen L, Mors O, Mortensen PB, Yolken RH, Gasse C, Benros ME.

Acta Psychiatr Scand. 2017 Feb;135(2):97-105

Infection and inflammation in schizophrenia and bipolar disorder

Tanaka T, Matsuda T, Hayes LN, Yang S, Rodriguez K, Severance EG,Yolken RH, Sawa A, Eaton WW. Neurosci Res. 2017 Feb;115:59-63

Maternal mid-pregnancy C-reactive protein and risk of autism spectrum disorders: the early markers for autism study

Zerbo O, Traglia M, Yoshida C, Heuer LS, Ashwood P, Delorenze GN, Hansen RL, Kharrazi M, Van de Water J, Yolken RH, Weiss LA, Croen LA.

Trnsl Psychiatry. 2016 Apr 19;6:e783

Prenatal and newborn immunoglobulin levels from mother-child pairs and risk of autism spectrum disorders

Grether JK, Ashwood P, Van de Water J, Yolken RH, Anderson MC, Torres AR, Westover JB, Sweeten T, Hansen RL, Kharrazi M, Croen LA.

Front Neurosci. 2016 May 18;10:218

Probiotic normalization of Candida albicans in schizophrenia: A randomized, placebo-controlled, longitudinal pilot study

Severance EG, Gressitt KL, Stallings CR, Katsafanas E. Schweinfurth LA, Savage CL, Adamos MB, Sweeney KM, Origoni AE, Khushalani S, Dickerson FB, Yolken RH.

Brain Behav Immun. 2017 May;62:41-45

Race is associated with sexual behaviors and modifies the effect of age on Human Papillomavirus Serostatus among perimenopausal women

Rettig EM, Fakhry C, Rositch AF, Burke AE, Chang K, Silver MI, Viscidi R, Gravitt P.

Sex Transm Dis. 2016 Apr;43(4):231-7

Reduced superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with early psychosis in association with clinical features

Coughlin JM, Hayes LN, Tanaka T. Xiao M, Yolken RH, Worley P, Leweke FM, Sawa A.

Schizophr Res. 2016 Nov 23. S0920-9964(16)30492-3

Schizophrenia and infections: The eyes have it

Torrey EF, Yolken RH.

Schizophr Bull. 2017 Mar 1;43(2):247-252

Serum antibodies to HPV16 early proteins warrant investigation as potential biomarkers for risk stratification and recurrence of HPV-associated oropharyngeal cancer

Fakhry C, Qualliotine JR, Zhang Z, Agrawal N, Gaykalova DA, Bishop JA, Subramaniam RM, Koch WM, Chung CH, Eisele DW, Califano J, Viscidi RP.

Cancer Prev Res (Phila). 2016 Feb;9(2):135-41

Stability of Toxoplasma gondii: Antibody levels in schizophrenia

Yuksel P, Kocazeybek B, Ozdemir A, Yolken RH, Torrey EF.

Schizophr Res. 2017 Feb 27 (S0920-9964)

Suicide attempts and markers of immune response in individuals with serious mental illness

Dickerson F, Wilcox HC, Adamos M, Katsafanas E, Khushalani S, Origoni A, Savage C, Schweinfurth L, Stallings C, Sweeney K, Yolken R.

J Psychiatr Res. 2017 Apr;87:37-43

The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls

Dickerson F, Adamos MB, Katsafanas E, Khushalani S, Origoni A, Savage CL, Schroeder J, Schweinfurth LA, Stallings C, Sweeney K, Yolken R.

Schizophr Res. 2016 Oct;176(2-3):566-71

The gut microbiota and the emergence of autoimmunity: Relevance to major psychiatric disorders

Severance EG, Tveiten D, Lindstrom LH, Yolken RH, Reichelt KL.

Curr Pharm Des. 2016;22(40):6076-6086

The microbiome, immunity, and schizophrenia and bipolar disorder

Dickerson F, Severance E, Yolken R.

Brain Behav Immun. 2017 May;62:46-52

Toxoplasma gondii-A gastrointestinal pathogen associated with human brain diseases

Severance EG, Xiao J, Jones-Brando L, Sabunciyan S, Li Y, Pletnikov M, Prandovszky E, Yolken R.

Int Rev Neurobiol. 2016;131:143-163

Toxoplasma gondii exposure may modulate the influence of TLR2 genetic variation on bipolar disorder: a gene-environment interaction study

Oliveira J, Kazma R, Le Floch E, Bennabi M, Hamdani N, Bengoufa D, Dahoun M, Manier C, Bellivier F, Krishnamoorthy R, Deleuze JF, Yolken R, Leboyer M, Tamouza R.

Int J Bipolar Disorder. 2016 Dec;4(1):11

Toxoplasmosis titers and past suicide attempts among older adolescents initiating SSRI treatment

Coryell W, Yolken R, Butcher B, Burns T, Dindo L, Schlechte J, Calarge C.

Arch Suicide Res. 2016 Oct-Dec;20(4):605-13

Widespread splicing of repetitive element loci into coding regions of gene transcripts

Darby MM, Leek JT, Langmead B, Yolken RH, Sabunciyan S.

Hum Mol Genet. 2016 Nov 15;25(22):4962-4982.

A DANISH NATIONAL BIRTH COHORT STUDY OF MATERNAL HSV-2 ANTIBODIES AS A RISK FACTOR FOR SCHIZOPHRENIA IN THEIR OFFSPRING

VALIDATION OF A BLOOD-BASED LABORATORY TEST TO AID IN THE CONFIRMATION OF A DIAGNOSIS OF SCHIZOPHRENIA

NOVEL IMMUNE RESPONSE TO GLUTEN IN INDIVIDUALS WITH SCHIZOPHRENIA

MARKERS OF GLUTEN SENSITIVITY AND CELIAC DISEASE IN RECENT-ONSET PSYCHOSIS AND MULTI-EPISODE SCHIZOPHRENA

GREY MATTER CHANGES ASSOCIATED WITH HOST GENETIC VARIATION AND EXPOSURE TO HERPES SIMPLEX VIRUS 1 (HSV1) IN FIRST EPISODE SCHIZOPHRENIA

TOXOPLASMA GONDII STRAIN-DEPENDENT EFFECTS ON MOUSE BEHAVIOUR

NEUROANATOMIC AND COGNITIVE ABNORMALITIES RELATED TO HERPES SIMPLEX VIRUS TYPE 1 IN SCHIZOPHRENIA

THIAZOLE, OXADIAZOLE, AND CARBOXAMIDE DERIVATIVES OF ARTEMISININ ARE HIGHLY SELECTIVE AND POTENT INHIBITORS OF TOXOPLASMA GONDII

SUBUNIT AND WHOLE MOLECULE SPECIFICITY OF THE ANTI-BOVINE CASEIN IMMUNE RESPONSE IN RECENT ONSET PSYCHOSIS AND SCHIZOPHRENIA

ANTIBODIES TO MEASLES IN INDIVIDUALS WIT H RECENT ONSET PSYCHOSIS

ARTEMISININ DERIVATIVES INHIBIT TOXOPLASMA GONDII IN VITRO AT MULTIPLE STEPS IN THE LYTIC CYCLE

TOXOPLASMA AND SCHIZOPHRENIA

TOXOPLASMA GONDII ANTIBODY TITERS AND HISTORY OF SUICIDE ATTEMPTS IN PATIENTS WITH RECURRENT MOOD DISORDERS

INFECTION AND THYROID AUTOIMMUNITY: A SEROEPIDEMIOLOGIC STUDY OF TPOaAB

EFFECTS OF TYPICAL AND ATYPICAL ANTIPSYCHOTIC DRUGS ON GENE EXPRESSION PROFILES INT EH LIER OF SCHIZOPHRENIA SUBJECTS

CANDIDATE GENES AND THEIR INTERACTIONS WITH OTHER GENETIC/ENVIRONMENTAL RISK FACTORS IN THE ETIOLOGY OF SCHIZOPHRENIA

PATERNAL AGE AS A RISK FACTOR FOR SCHIZOPHRENIA: HOW IMPORTANT IS IT?

SEROLOGICAL PATTERN CONSISTENT WITH INFECTION WITH TYPE 1 TOXOPLASMA GONDII IN MOTHERS AND RISK OF PSYCHOSIS AMONG ADULT OFFSPRING

THE HUMAN COLON CANCER METHYLOME SHOWS SIMILAR HYPO- AND HYPERMETHYLATION AT CONSERVED TISSUE-SPECIFIC CpG ISLAND SHORES

CORONAVIRUS IMMUNOREACTIVITY IN INDIVIDUALS WITH A RECENT ONSET OF PSYCHOTIC SYMPTOMS

A DOUBLE BLIND TRIAL OF ADJUNCTIVE ALLOPURINOL FOR SCHIZOPHRENIA

COGNITIVE FUNCTIONING PRIOR TO THE ONSET OF PSYCHOSIS: THE ROLE OF FETAL EXPOSURE TO SEROLOGICALLY DETERMINE INFLUENZA INFECTION

DIFFERENTIATING NICOTINE- VERSUS SCHIZOPHRENIA-ASSOCIATED DECREASES OF THE ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR TRANSCRIPT, CHRFAM7A, IN PERIPHERAL BLOOD LYMPHOCYTES

PREDICTORS OF OCCUPATIONAL STATUS SIX MONTHS AFTER HOSPITALIZATION IN PERSONS WITH A RECENT ONSET OF PSYCHOSIS

SELECTED INFECTIOUS AGENTS AND RISK OF SCHIZOPHRENIA AMONG U.S. MILITARY PERSONNEL

COMPREHENSIVE EVALUATION OF POSITIONAL CANDIDATES IN THE IL-18 PATHWAY REVEALS SUGGESTIVE ASSOCIATIONS ITH SCHIZOPHRENIA AND HERPES VIRUS SEROPOSITIVITY

MATERNAL THYROID AUTOANTIBODIES DURING THE THIRD TRIMESTER AND HEARING DEFICITS IN CHILDREN: AN EPIDEMIOLOGIC ASSESSMENT

RESULTS FROM A HYPOTHESIS GENERTING CASE-CONTROL STUDY: HERPES FAMILY VIRUSES AND SCHIZOPHRENIA AMONG MILITARY PERSONNEL

ARE SOME CASES OF PSYCHOSIS CAUSED BY MICROBIAL AGENTS? A REVIEW OF THE EVIDENCE

DECREASED NEUROTROPIC RESPONSE TO BIRTH HYPOXIA IN THE ETIOLOGY OF SCHIZOPHRENIA

ASSOCIATION BETWEEN COGNITIVE FUNCTIONING, EXPOSURE TOHERPES SIMPLEX VIRUS TYPE 1 AND THE COMPT VAL158MET GENETIC POLYMORPHISM IN ADULTS WITHOUT A PSYCHIATRIC DISORDER

POLYMORPHISMS IN HUMAN ENDOGENOUS RETROVIRUS K-18 AND RISK OF TYPE 2 DIABETES IN INDIVIDUALS WITH SCHIZOPHRENIA

POLYMORPHISMS IN MICB ARE ASSOCATED WITH HUMAN HERPES VIRUS SEROPOSITIVITY AND SCHIZOHRENIA RISK

DNA METHYLATION SIGNTURES WITHIN HTE HUMAN BRAIN

MATERNAL EXPOSURE TO HERPES SIMPLEX VIRUS AND RISK OF PSYCHOSIS AMONG ADULT OFFSPRING

META-ANALYSIS OF 12 GENOMIC STUDIES IN BIPOLAR DISORDER

LACK OF RIC-3 CONGRUENCE WITH BETA2 SUBUNIT-CONTAINING NICTINIC ACETYLCHOLINE RECEPTORS IN BIPOLAR DISORDER

THE ASSOCIATION BETWEEN COGNITIVE FUNCTIONING AND OCCUPATIONAL STATUS IN PERSONS WITH A RECENT ONSET OF PSYCHOSIS

THE CATECHOL O-METHYLTRANSFERASE VAL158MET POLYMORPHISM IS NOT ASSOCIATED WITH BROAD-BASED COGNITIVE FUNCTIONING IN SCHIZOPHRENIA

ELEVATED LEVELS OF HUMAN ENDOGENOUS RETROVIRUS-W TRANSCRIPTS IN BLOOD CELLS FROM PATIENTS WITH FIRST EPISODE SCHIZOPHRENIA

POLYMORPHISMS IN MICB ARE ASSOCIATED WITH HUMAN HERPES VIRUS SEROPOSITIVITY AND SCHIZOPHRENIA RISK

ELEVATED LEVELS OF HUMAN ENDOGENOUS RETROVIRUS-W TRANSCRIPTS IN BLOOD CELLS FROM PATIENTS WITH FIRST-EPISODE SCHIZOPHRENIA

POLYMORPHISMS IN THE HOMEOBOX GENE OTX2 MAY BE A RISK FACTOR FOR BIPOLR DISORDER

LACK OF RIC-3 CONGRUENCE WITH BETA2 SUBUNIT-CONTAINING NICOTINIC ACETYLCHOLINE RECEPTORS IN BIPOLAR DISORDER

EARLY INFECTIONS OF TOXOPLASMA GONDII AND THE LATER DEVELOPMENT OF SCHIZOPHRENIA

REDUCED EXPRESSION OF HUMAN ENDOGENOUS RETROVIRUS (HERV)-W GAG PROTEIN IN THE CINGULATE GYRUS AND HIPPOCAMPUS IN SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION

ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS

C-REACTIVE PROTEIN IS ASSOCIATED WITH THE SEVERITY OF COGNITIVE IMPAIRMENT BUT NOT OF PSYCHIATRIC SYMPTOMS IN INDIVIDUALS WITH SCHIZOPHRENIA

ELEVATED SERUM LEVELS OF C-REACTIVE PROTEIN ARE ASSOCIATED WITH MANIA SYMPTOMS IN OUTPATIENTS WITH BIPOLAR DISORDER

ARE EXPOSURE TO CYTOMEGALOVIRUS AND GENETIC VARIATION ON CHROMOSOME 6P JOINT RISK FACTORS FOR SCHIZOPHRENIA?

NOVEL ALPHA7 NICOTINIC RECEPTOR ISOFORMS AND DEFICIENT CHOLINERGIC TRANSCRIPTION IN SCHIZOPHRENIA

POPULATION GENETIC ESTIMATION OF THE LOSS OF GENETIC DIVERSITY DURING HORIZONTAL TRANSMISSION OF HIV-1

SEROLOGICAL DETECTION OF HUMAN PAPILLOMAVIRUS TYPE 16 INFECTION IN HUMAN IMMUNODEFICIENCY VIRUS (HIV)-POSITIVE AND HIGH-RISK HIV-NEGATIVE WOMEN

SEROLOGICAL CROSS REACTIVITY BETWEEN POLYOMAVIRUS CAPSIDS

TEMPLE MONKEYS AND HEALTH IMPLICATIONS OF COMMENSALISM, KATHMANDU, NEPAL

PHYLOGENOMICS AND MOLECULAR EVOLUTION OF POLYOMAVIRUSES

PREDIAGNOSTIC CIRCULATING ANTIBODIES TO JC AND BK HUMAN POLYOMAVIRUSES AND RISK OF NON-HODGKIN LYMPHOMA

COMPARING PHYLOGENETIC CODIVERGENCE BETWEEN POLYOMAVIRUSES AND THEIR HOSTS

TOXOPLASMA GONDII AS A RISK FACTOR FOR EARLY ON-SET SCHIZOPHRENIA: ANALYSIS OF FILTER PAPER BLOOD SAMPLES OBTAINED AT BIRTH

CELLULAR IMMUNE RESPONSES TO HPV-18, -31, AND -53 IN HEALTHY VOLUNTEERS IMMUNIZED WITH RECOMBINANT HPV-16 L1 VIRUS-LIKE PARTICLES

PREVALENCE OF SERUM ANTIBODIES TO HUMAN PAPILLOMA VIRUS IN PATIENTS WITH GENITAL ULCER DISEASE IN AN URBAN POPULATION OF TANZANIA

TRANSACTIVATION OF ELEMENTS IN THE HUMAN ENDOGENOUS RETROVIRUS W FAMILY BY VIRAL INFECTION

EVOLUTION OF THE HUMAN IMMUNODEFICIENCY VIRUS ENVELPE GENE IS DOMINATED BY PURIFYING SELECTION

IMMUNOGLOBULIN G, A, AND M RESPONSES TO BK VIRUS IN RENAL TRANSPLANTATION

DEFICIT SCHIZOPHRENIA: ASSOCIATION WITH SERUM ANTIBODIES TO CYTOMEGALOVIRUS

VACCINATION OF HEALTHY VOLUNTEERS WITH HUMAN PAPILLOMAVIRUS TYPE 16 L2E7E6 FUSION PROTEIN INDUCES SERUM ANTIBODY THAT NEUTRALIZES ACROSS PAPILLOMAVIRUS SPECIES

TEMPORAL TRENDS IN GONOCOCCAL POPULATION GENETICS IN A HIGH PREVALENCE URBAN COMMUNITY

CHANGES IN REGION- AND CELL TYPE-SPECIFIC EXPRESSION PATTERNS OF NEUTRAL AMINO ACID TRANSPORTER 1 (ASCT-1) IN THE ANTERIOR CINGULATE CORTEX AND HIPPOCAMPUS IN SCHIZOPHRENIA, BIPOLAR DISORDER AND MAJOR DEPRESSION

SEROPREVALENCE OF HUMAN PAPILLOMAVIRUS TYPES 16 AND 18 IN THE GENERAL POPULATION IN THE GENERAL POPULATION IN TAIWAN: IMPLICATION FOR OPTIMAL AGE OF HUMAN PAPILLOMAVIRUS VACCINATION

INFECTIOUS AGENTS AND GENE–ENVIRONMENTAL INTERACTIONS IN THE ETIOPATHOGENESIS OF SCHIZOPHRENIA

INFECTIOUS AGENTS AND GENE–ENVIRONMENTAL INTERACTIONS IN THE ETIOPATHOGENESIS OF SCHIZOPHRENIA

UPREGULATION OF THE INITIATING STEP OF THE KYNURENINE PATHWAY IN POSTMORTEM ANTERIOR CINGULATE CORTEX FROM INDIVIDUALS WITH SCHIZOPHRENIA AND BIPOLAR DISORDER

THE NATURAL HISTORY OF HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL INTRAEPITHELIAL NEOPLASMIA AMONG YOUNG WOMEN IN GHE GUANACASTE COHORT SHORTLY AFTER INITIATION OF SEXUAL LIFE

IN VITRO INHIBITION OF TOXOPLASMA GONDII BY FOUR NEW DERIVATIVES OF ARTEMISININ

ALTERED TRANSCRIPTIONAL ACTIVITY OF HUMAN ENDOGENOUS RETROVIRUSES IN NEUROEPITHELIAL CELLS AFTER INFECTION WITH TOXOPLASMA GONDII

BRAIN MORPHOLOGICAL CHANGES ASSOCIATED WITH EXPOSURE TO HSV1 IN FIRST-EPISODE SCHIZOPHRENIA

TOXOPLASMA GONDII AS A RISK FACTOR FOR EARLY-ONSET SCHIZOPHRENIA: ANALYSIS OF FILTER PAPER BLOOD SAMPLES OBTAINED AT BIRTH

ASSOCIATION STUDY OF IL10, IL1BETA, AND IL1RN AND SCHIZOPHRENIA USING TAG SNPs FROM A COMPREHENSIVE DATABASE: SUGGESTIVE ASSOCIATION WITH RS16944 AT IL1BETA

THE LYMPHOTOXIN CYS13ARG POLYMORPHISM AND COGNITIVE FUNCTIONING IN INDIVIDUALS WITH SCHIZOPHRENIA

DISC1-NDEL1/NUDEL PROTEIN INTERACTION, AN ESSENTIAL COMPONENT FOR NEURITE OUTGROWTH, IS MODULATED BY GENETIC VARIATIONS OF DISC1

CYTOMEGALOVIRUSES AND SCHIZOPHRENIA

NEUROPSYCHOLOGICAL FUNCTION IN BIPOLAR DISORDER AND SCHIZPHRENIA

ANTIBODIES TO TOXOPLASMA GONDII IN PATIENTS WITH SCHIZOPHRENIA: A META-ANALYSIS

REDUCED EXPRESSION OF HUMAN ENDOGENOUS RETROVIRUS (HERV)-W GAG PROTEIN IN THE CINGULATE GYRUS AND HIPPOCAMPUS IN SCHIZOPHRENIA, BIPOLAR DISORDER, AND DEPRESSION

ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS

HSV1 EXPOSURE AFFECTS PREFRONTAL CORTICAL STRUCTURE IN SCHIZOPHRENIA PATIENTS

MITOCHONDRIAL DYSFUNCTION IN SCHIZOPHRENIA: EVIDENCE FOR COMPROMISED BRAIN METALOLISM AND OXIDATIVE STRESS

VIRUSES AND SCHIZOPHRENIA; A FOCUS ON HERPES SIMPLEX VIRUS

COGNITIVE FUNCTIONING IN SCHIZOPHRENIA AND BIPOLAR DISORDER: COMPARISON OF PERFORMANCE ON THE REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS

AUTISM AND HAD CIRCUMFERENCE IN THE FIRST YEAR OF LIFE

A COMPREHENSIVE GENETIC ASSOCIATION AND FUNCTIONAL STUDY OF TNF IN SCHIZOPHRENIA RISK

DEFICIT SCHIZOPHRENIA: ASSOCIATION WITH SERUM ANTIBODIES TO CYTOMEGALOVIRUS

MUMPS VIRUS-SPECIFIC ANTIBODY TITERS FROM PRE-VACCINE ERA SERA: COMPARISON OF THE PLAQUE REDUCTION NEUTRALIZATION ASSAY AND ENZYME IMMUNOASSAYS

EVALUATING RNA STATUS FOR RT-PCR IN EXTRACTS OF POSTMORTEM HUMAN BRAIN TISSUE

ANTIBODIES TO INFECTIOUS AGENTS IN INDIVIDUALS WITH RECENT ONSET SCHIZOPHRENIA

ASSOCIATION BETWEEN COGNITIVE FUNCTIONING AND EMPLOYMENT STATUS OF PERSONS WITH BIPOLAR DISORDER

ASSOCIATION OF SERUM ANTIBODIES TO HERPES SIMPLEX VIRUS 1 WITH COGNITIVE DEFICITS IN INDIVIDUALS WITH SCHIZOPHRENIA

DRUGS USED IN THE TREATMENT OF SCHIZOPHRENIA AND BIPOLAR DISORDER INHIBIT THE REPLICATION OF TOXOPLASMA GONDII

EPIGENETIC STUDIES OF GENOMIC RETROELEMENTS IN MAJOR PSYCHOSIS

EXPRESSION OF KYNURENINE PATHWAY ENZYME TRYPTOPHAN 2

HERPESVIRUSES AND TOXOPLASMA GONDII IN ORBITAL FRONTAL CORTEX OF PSYCHIATRIC PATIENTS

INFECTION WITH HERPES SIMPLEX VIRUS TYPW 1 IS ASSOCIATED WITH COGNITIVE DEFICITS IN BIPOLAR DISORDER

LOW MATERNAL VITAMIN D AS A RISK FACTOR FOR SCHIZOPHRENIA

NO DETECTION OF PARVOVIRUS B19 OR HERPESVIRUS DNA IN GIANT CELL ARTERITIS

OLIGODENDROCYTE DYSFUNCTION IN SCHIZOPHRENIA AND BIPOLAR DISORDER

PSYCHOPATHOLOGY IN FIRST-EPISODE SCHIZOPHRENIA AND ANTIBODIES TO TOXOPLASMA GONDII

TOXOPLASMA GONDII AND SCHIZOPHRENIA